Holen Sie sich die Stockscreener-App
0.7107
12.37%
-0.1003
Handel nachbörslich:
.71
-0.0007
-0.10%
Schlusskurs vom Vortag:
$0.811
Offen:
$0.7774
24-Stunden-Volumen:
43,572
Relative Volume:
0.07
Marktkapitalisierung:
$6.72M
Einnahmen:
$453.30K
Nettoeinkommen (Verlust:
$-1.03M
KGV:
-6.2783
EPS:
-0.1132
Netto-Cashflow:
-
1W Leistung:
-6.66%
1M Leistung:
-32.95%
6M Leistung:
-85.74%
1J Leistung:
-86.79%
1-Tages-Spanne:
$0.7107
$0.78
1-Wochen-Bereich:
$0.655
$0.811
52-Wochen-Spanne:
$0.5301
$10.28
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Company Profile
Firmenname
X T L Biopharmaceuticals Ltd Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare XTLB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XTLB
X T L Biopharmaceuticals Ltd Adr
|
0.7107 | 7.67M | 453.30K | -1.03M | 0 | -0.1132 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
X T L Biopharmaceuticals Ltd Adr Stock (XTLB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-05-08 | Eingeleitet | H.C. Wainwright | Buy |
X T L Biopharmaceuticals Ltd Adr Aktie (XTLB) Neueste Nachrichten
XTL Biopharmaceuticals Faces Nasdaq Delisting After “Public Shell” Determination - The Globe and Mail
XTL Biopharmaceuticals stock falls on Nasdaq delisting notice - Investing.com
XTL Biopharmaceuticals Shareholders Approve Capital Increase and NeuroNOS-Linked Private Placement - TipRanks
XTL Biopharmaceuticals Faces Liquidation of Web Data Subsidiary After Insolvency Ruling - TipRanks
XTL Biopharmaceuticals Adjourns Extraordinary Shareholders Meeting for Lack of Quorum - The Globe and Mail
XTLB Stock Price, Forecast & Analysis | XTL BIOPHARMACEUTICALS-ADR (NASDAQ:XTLB) - ChartMill
XTL Biopharmaceuticals announces CFO transition amid strategic appointments - MSN
XTL Biopharmaceuticals Advances NeuroNOS Acquisition and Plans $2 Million Private Placement to Address Nasdaq Equity Deficiency - TipRanks
XTL Biopharmaceuticals Faces Subsidiary Insolvency Filing, Reviews $1.5 Million Loan Exposure - TipRanks
XTL Biopharmaceuticals Flags Nasdaq Equity Deficiency, Given Deadline to Regain Compliance - TipRanks
XTL Biopharmaceuticals Calls February 17 Extraordinary Meeting to Expand Share Capital and Approve NeuroNOS-Linked Financing - The Globe and Mail
Beyond Air Deals Autism-Focused NeuroNOS To XTL For Equity, Future Payments - Benzinga
XTL Biopharmaceuticals Moves to Acquire NeuroNOS Stake from Beyond Air and Plans $2 Million Private Placement - TipRanks
XTL Biopharmaceuticals Takes Major Impairment on The Social Proxy in First-Half 2025 Results - The Globe and Mail
XTL Biopharmaceuticals Faces Nasdaq Bid-Price Deficiency, Given Until June 2026 to Regain Compliance - TipRanks
12 Health Care Stocks Moving In Tuesday's After-Market Session - Sahm
XTL Biopharmaceuticals Faces Leadership Changes at Social Proxy Subsidiary - The Globe and Mail
XTL Biopharmaceuticals Announces CFO Transition Amid Strategic Appointments - The Globe and Mail
Total debt per share of XTL Biopharmaceuticals Ltd. Sponsored ADR – LS:A2DK34 - TradingView
These stocks that are showing activity before the opening bell on Friday. - Chartmill
Changes in working capital of XTL Biopharmaceuticals Ltd. Sponsored ADR – FWB:H2K2 - TradingView
XTL Biopharmaceuticals Announces Board Changes Following Resignation - MSN
XTL Biopharmaceuticals: Shifting Gears or Grounded Reality? - StocksToTrade
XTL Biopharmaceuticals Enters Sublicense Agreement with Biossil - TipRanks
XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD. - Nasdaq
symbol__ Stock Quote Price and Forecast - CNN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.03% - Investing.com India
Unusual VolumeStock ScreenerNews - Finviz
XTLB Stock Price and Chart — NASDAQ:XTLB - TradingView
XTL Biopharmaceuticals Ltd Share Price ADR Each Repr 100 Shs Spon - Hargreaves Lansdown
XTLB Financial Statements & ChartsX.t.l. Biopharmaceuticals Ltd.Adr MacroTrends - CMLviz
XTLB Pivot Points, Technical Analysis and Moving AveragesX.t.l. Biopharmaceuticals Ltd.Adr Technicals - CMLviz
The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates - Yahoo Finance
List of US Companies Releasing Earnings (EPS) Today - FXLeaders
The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher - Benzinga
XTLB Stock Price and Chart — TASE:XTLB - TradingView
XTLB Stock Price | XTL Biopharmaceuticals Ltd. ADR Stock Quote (U.S.: Nasdaq) - MarketWatch
Check out X T L Biopharmaceuticals Ltd's stock price (XTLB) in real time - CNBC
XTLBX.T.L. Biopharmaceuticals Ltd. ADR Stock Price and Quote - Finviz
INGN Stock Price | Inogen Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch
Finanzdaten der X T L Biopharmaceuticals Ltd Adr-Aktie (XTLB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):